7,541.40

-38.67

-0.51%

51,983.98

+213.67

+0.41%

25,164.32

-272.68

-1.07%

2,805.88

-5.97

-0.21%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,956.60

+57.70

+1.48%

76,734.34

-969.73

-1.25%

Crude Oil Dec 26

96.26

-7.86

-7.55%

US Private Equity

10,850.63

-82.20

-0.75%

LIVE It’s John Ternus’ first earnings call as Apple CEO. Listen in here.

Oslo - Delayed Quote NOK

Oncoinvent ASA (ONCIN.OL)

65.40 -3.60 (-5.22%)

At close: 4:25:12 PM GMT+1

Oncoinvent ASA (STU:7BG) (Q2 2026) Earnings Call Highlights: Ovarian Cancer Trial Hits Halfway ...

GuruFocus.com 2mo ago

ONCIN.OL
-5.22%
7BG.SG
Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine

PR Newswire 2mo ago

ONCIN.OL
-5.22%
ONCIN@NO

NO0013711713
Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine

PR Newswire 2mo ago

NO0013711713

ONCIN.OL
-5.22%
ONCIN@NO
Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin®

PR Newswire 4mo ago

NO0013711713

ONCIN

ONCIN.OL
-5.22%
Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin®

PR Newswire 4mo ago

ONCIN

ONCIN@NO

NO0013711713

Mobilize your Website

View Site in Mobile | Classic

Share by: